Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2002 Sep;129(3):385-9.
doi: 10.1046/j.1365-2249.2002.01967.x.

High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders

S Jolles
Editorial

High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders

S Jolles. Clin Exp Immunol. 2002 Sep.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Jolles S, Hughes J, Whittaker S. Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol. 1998;134:80–6. - PubMed
    1. Sewell WAC, Jolles S. Immunomodulatory action of Intravenous Immunoglobulin (IVIG) mmunology. 2002 in press. - PMC - PubMed
    1. Hall R, Murray J. Autoimmune skin disease. In: Rich R, editor. Clinical immunology principles and practice. Vol. 2. St. Louis, MO: Mosby; 1996. pp. 1316–42.
    1. Tappeiner G, Steiner A. High-dosage intravenous gamma globulin. therapeutic failure in pemphigus and pemphigoid. J Am Acad Dermatol. 1989;20:684–5. - PubMed
    1. Humbert P, Derancourt C, Aubin F, Agache P. Effects of intravenous gamma-globulin in pemphigus. J Am Acad Dermatol. 1990;22:326. - PubMed

MeSH terms

Substances